Mineralys Therapeutics Inc.

MLYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.31

+$0.29 (+1.03%)

At close: Sep 21, 2026, 4:00 PM ET

$28.01

-$0.30 (-1.06%)

Pre-market: Sep 22, 2026, 4:10 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-154.65M	-177.81M	-71.9M	-29.8M	-19.41M	-3.43M
Depreciation & Amortization	59K	43K	n/a	n/a	n/a	n/a
Stock-Based Compensation	19.32M	11.34M	5.06M	455K	80K	1K
Other Working Capital	2.9M	9.1M	-7.12M	772K	4.09M	480K
Other Non-Cash Items	-9.88M	-9.41M	-6.87M	-649K	684K	482K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.73M	9.52M	-7.47M	772K	4.09M	480K
Operating Cash Flow	-142.42M	-166.31M	-81.17M	-29.22M	-14.56M	-2.46M
Capital Expenditures	-15K	-96K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-814.74M	-373.45M	-347.97M	-71.76M	n/a	n/a
Sales Maturities Of Investments	425M	488.5M	187.5M	50M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-389.75M	114.96M	-160.47M	-21.76M	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	3.85M
Common Stock Repurchased	n/a	n/a	n/a	-1.63M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	83K	258K	n/a	n/a	n/a
Financial Cash Flow	591M	116.14M	203.25M	128.02M	23.81M	3.83M
Net Cash Flow	58.83M	64.79M	-38.4M	77.04M	9.25M	1.41M
Free Cash Flow	-142.43M	-166.41M	-81.17M	-29.22M	-14.56M	-2.46M
Adj. Free Cash Flow	-161.76M	-177.75M	-86.23M	-29.68M	-14.64M	-2.46M
Maintenance CapEx	-15K	-43K	n/a	n/a	n/a	n/a
Growth CapEx	n/a	-53K	n/a	n/a	n/a	n/a
Owner Earnings	-142.43M	-166.36M	-81.17M	-29.22M	-14.56M	-2.46M